Clinical Trial Update: Bevacizumab and Letrozole in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer That Cannot Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Bevacizumab plus Letrozole for postmenopausal women with locally advanced or metastatic breast cancer not removable by surgery…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Avastin (bevacizumab)
• FEMARA (letrozole)

Snippet

Sponsor: University of California, San Francisco | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED